Spots Global Cancer Trial Database for clinical trial
Every month we try and update this database with for clinical trial cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma | NCT00434161 | Multiple Myelom... | Palifermin befo... Placebo Palifermin befo... | 18 Years - 70 Years | Swedish Orphan Biovitrum | |
Comparative Study of Laparoscopic Versus Open Operations for Colon Cancer | NCT00202111 | Colonic Neoplas... | Laparoscopic-as... Conventional op... | 18 Years - | The Queen Elizabeth Hospital | |
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer | NCT00393822 | Colon Cancer | palifermin placebo | 18 Years - | Amgen | |
Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced Disease | NCT04630743 | Dyspnea Respiratory Ins... Neoplasms Pulmonary Disea... Lung Diseases Heart Failure Lung Diseases, ... Palliative Care Palliative Medi... Breathlessness | Cognitive and B... | 18 Years - | University of Cologne | |
Phase I Study of AT13148, a Novel AGC Kinase Inhibitor | NCT01585701 | Advanced Solid ... | AT13148 | 18 Years - | Cancer Research UK | |
A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia | NCT00117039 | Anemia Neoplasms | Aranesp® | 18 Years - | Amgen | |
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | NCT03452774 | Cancer, Metasta... Cancer Cancer of Pancr... Cancer of Liver Cancer of Stoma... Cancer Liver Cancer of Rectu... Cancer of Kidne... Cancer of Esoph... Cancer of Cervi... Cancer of Colon Cancer of Laryn... Cancer, Lung Cancer, Breast Cancer, Advance... Cancer Prostate Cancer of Neck Cancer of Skin Neuroendocrine ... Carcinoma Mismatch Repair... BRCA Gene Rearr... Non Hodgkin Lym... Leukemia Non Small Cell ... Cholangiocarcin... Glioblastoma Central Nervous... Melanoma Urothelial Carc... Bladder Cancer Ovarian Cancer Endometrial Can... Testicular Canc... Breast Cancer COVID Myelofibrosis Myeloproliferat... Myeloproliferat... Follicular Lymp... Mantle Cell Lym... Marginal Zone L... Myelodysplastic... | Clinical Trial ... | - | Massive Bio, Inc. | |
A Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer | NCT01220999 | Colorectal Neop... | CS-1008 | 18 Years - | Ludwig Institute for Cancer Research | |
A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa | NCT00119613 | Small Cell Lung... | placebo darbepoetin alf... | 18 Years - | Amgen | |
Passive Versus Active Educational Interventions for Melanoma Recognition | NCT04507048 | Educational Pro... Melanoma (Skin) | Active educatio... Passive educati... | 18 Years - 75 Years | Azienda Unità Sanitaria Locale Reggio Emilia | |
Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer | NCT00322400 | Locally Recurre... | Docetaxel Paclitaxel AMG 706 | 18 Years - | Amgen | |
Prospective Comparisons of Clinical Trial and Real-world Outcomes in Nasopharyngeal Carcinoma | NCT04108338 | Nasopharyngeal ... | Trial setting | 8 Years - 79 Years | Sun Yat-sen University | |
Oral Mucositis and Laser Therapy Associated With Photodynamic Therapy | NCT02555501 | Oral Mucositis | PDT + Low level... Low level laser | 3 Years - 18 Years | Universidade Ceuma | |
Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | NCT01245959 | Nasopharyngeal ... | Docetaxel, cisp... Concurrent chem... | 18 Years - 59 Years | Sun Yat-sen University | |
Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer | NCT00242190 | Pancreatic Neop... | oxaliplatin gemcitabine radiation thera... | 18 Years - | University of Michigan Rogel Cancer Center | |
Maintenance Treatment With Capecitabine Metronomic Chemotherapy and Chinese Traditional Medicine in Metastatic Colorectal Cancer | NCT02575378 | Metastatic Colo... | Metronimic chem... Metronimic chem... | 18 Years - 75 Years | Ruijin Hospital | |
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia | NCT01380756 | Cancer Hematologic Mal... Leukemia Myeloid Leukemi... | Arm 1- Dose Esc... Arm 2- Dose Exp... | 18 Years - | Amgen | |
Evaluation of An Online Intervention In Improving General Practitioners' Practice In Prostate Cancer Screening | NCT03633214 | Prostate Cancer... | Online training... | - | University of Malaya | |
Phase I Study of AT13148, a Novel AGC Kinase Inhibitor | NCT01585701 | Advanced Solid ... | AT13148 | 18 Years - | Cancer Research UK | |
Evaluation of An Online Intervention In Improving General Practitioners' Practice In Prostate Cancer Screening | NCT03633214 | Prostate Cancer... | Online training... | - | University of Malaya | |
Effect of White Light on Fatigue Levels in Patients With Gynecological Cancer | NCT05009693 | Cancer-related ... Light; Therapy,... | White Light App... | 18 Years - | Eskisehir Osmangazi University | |
Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid Leukemia | NCT02096289 | Acute Myeloid L... | Thioridazine | 55 Years - 80 Years | Ontario Clinical Oncology Group (OCOG) | |
The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy | NCT01248000 | Histologically ... | FDG-PET | 18 Years - | Gruppo Italiano Studio Linfomi | |
Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies | NCT01924689 | Solid Tumor Mal... | Clostridium nov... | 18 Years - | BioMed Valley Discoveries, Inc | |
Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer | NCT05262452 | Pancreatic Canc... Chemotherapy Ef... Ultrasound Ther... | ALPIUS 900, an ... FOLFIRINOX regi... | 19 Years - 85 Years | Seoul National University Hospital | |
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer | NCT00393822 | Colon Cancer | palifermin placebo | 18 Years - | Amgen | |
Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective Study | NCT02247453 | Lung Cancer | screening | 50 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma | NCT00416208 | Multiple Myelom... | Bortezomib | 61 Years - 75 Years | Janssen-Cilag G.m.b.H | |
Effect of White Light on Fatigue Levels in Patients With Gynecological Cancer | NCT05009693 | Cancer-related ... Light; Therapy,... | White Light App... | 18 Years - | Eskisehir Osmangazi University | |
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors | NCT00858377 | Advanced Malign... Advanced Solid ... Cancer Solid Tumors Tumors | Arm 1- Dose Esc... Arm 1- Dose Exp... | 18 Years - | Amgen | |
Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut | NCT00171873 | Neuroendocrine ... | Octreotide LAR ... Placebo | 18 Years - | Philipps University Marburg Medical Center | |
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer | NCT00131638 | Head and Neck C... | Placebo Palifermin | 18 Years - | Amgen | |
Economic Evaluation of Three Populational Screening Strategies for Cervical Cancer | NCT01373723 | Uterine Cervica... | Different alter... | 30 Years - 70 Years | Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | |
Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | NCT00094861 | Dysphagia Non-Small Cell ... Lung Cancer | Palifermin Placebo Radiotherapy Paclitaxel Carboplatin | 18 Years - | Swedish Orphan Biovitrum | |
Phase I Study of AT13148, a Novel AGC Kinase Inhibitor | NCT01585701 | Advanced Solid ... | AT13148 | 18 Years - | Cancer Research UK | |
Study to Compare Azacitidine Plus Pevonedistat Versus Azacitidine in Patients With Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy | NCT04090736 | Leukemia, Myelo... | Pevonedistat Azacitidine | 18 Years - | PETHEMA Foundation | |
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer | NCT00131638 | Head and Neck C... | Placebo Palifermin | 18 Years - | Amgen | |
Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality | NCT06338215 | All Cause Morta... Cardiovascular ... Invasive Cancer Liver Cirrhosis Type 2 Diabetes Depression Dementia Injury Traumati... Tuberculosis Infections | Moderate Alcoho... Abstention | 50 Years - 75 Years | Clinica Universidad de Navarra, Universidad de Navarra | |
Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial | NCT00907543 | Esophageal Neop... | Preoperative tr... Postoperative t... | 18 Years - | Lawson Health Research Institute | |
Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma | NCT00944801 | Glioblastoma | Pegylated Lipos... | 18 Years - 70 Years | University of Regensburg | |
Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery) | NCT04223999 | Recurrent Gliob... | Skullremodeling... Control | 18 Years - | University of Aarhus | |
QUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal Carcinoma | NCT00813605 | Metastatic Colo... | FOLFIRI AMG 655 Placebo AMG 479 | 18 Years - | NantCell, Inc. | |
Postoperative Bleeding Prevention in Massive Bone Tumour Resection | NCT02153593 | Blood Loss Bone Tumour | Tranexamic Acid Fibrin glue Electrocauteriz... | 18 Years - | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | |
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer | NCT00393822 | Colon Cancer | palifermin placebo | 18 Years - | Amgen | |
TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis | NCT00001862 | Juvenile Rheuma... Uveitis | Enbrel | - | National Institutes of Health Clinical Center (CC) | |
Surgical Treatment of Intra-spinal Canal Tumors Via Trans-Quadrant Channel | NCT02777398 | Spinal Neoplasm... | Trans-Quadrant ... Conventional Op... | 20 Years - 60 Years | First Affiliated Hospital Xi'an Jiaotong University | |
Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma | NCT02729506 | Hepatocellular ... | Transarterial R... Transarterial C... | 18 Years - 80 Years | King Faisal Specialist Hospital & Research Center | |
GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer | NCT00157573 | Ovarian Cancer Fallopian Tube ... | GM-CSF, sargram... | 18 Years - | Massachusetts General Hospital | |
Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma | NCT00332969 | Thymoma | Octreotide | 18 Years - | Novartis | |
Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies | NCT01924689 | Solid Tumor Mal... | Clostridium nov... | 18 Years - | BioMed Valley Discoveries, Inc | |
Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC | NCT03366883 | Esophageal Canc... Esophageal Canc... | Paclitaxel, Cis... radiochemothera... | 20 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
Study of NY-ESO-1 ISCOMATRIX® in Patients With Measurable Stage III or IV Melanoma | NCT00518206 | Melanoma | NY-ESO-1 ISCOMA... Cyclophosphamid... | 18 Years - | Ludwig Institute for Cancer Research | |
Surgical Treatment of Intra-spinal Canal Tumors Via Trans-Quadrant Channel | NCT02777398 | Spinal Neoplasm... | Trans-Quadrant ... Conventional Op... | 20 Years - 60 Years | First Affiliated Hospital Xi'an Jiaotong University | |
Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone | NCT00339183 | Metastatic Colo... | Panitumumab FOLFIRI | 18 Years - | Amgen | |
Phase II Trial of Allovectin-7® for Metastatic Melanoma | NCT00044356 | Melanoma Metastatic Mela... Malignant Melan... Skin Cancer | Allovectin-7® | 18 Years - | Vical | |
Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma | NCT00944801 | Glioblastoma | Pegylated Lipos... | 18 Years - 70 Years | University of Regensburg | |
Factors Influencing Cancer Patients Participation in Clinical Trials in China. | NCT03412344 | Cancer | 18 Years - 75 Years | ChineseAMS | ||
Phase I Study of AT13148, a Novel AGC Kinase Inhibitor | NCT01585701 | Advanced Solid ... | AT13148 | 18 Years - | Cancer Research UK | |
Photobiomodulation in Oral Lesions Resulting From Anti-neoplastic Prevention | NCT04717765 | Oral Mucositis Osteoradionecro... Osteonecroses, ... Osteonecrosis D... Hyposalivation Head and Neck C... Oral Cancer | Preventive, LLL... Curative, LLL P... Preventive, LLL... Curative, LLL P... | 18 Years - | University of Santiago de Compostela | |
Calcitriol in Advanced Intrahepatic Cholangiocarcinoma | NCT01039181 | Advanced Intrah... | Calcitriol | 30 Years - 65 Years | National Science and Technology Development Agency, Thailand | |
A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM) | NCT04573140 | Adult Glioblast... | Autologous tota... | 21 Years - | University of Florida | |
Factors Influencing Cancer Patients Participation in Clinical Trials in China. | NCT03412344 | Cancer | 18 Years - 75 Years | ChineseAMS | ||
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy | NCT00540332 | Head and Neck C... | Placebo palifermin | 18 Years - | Swedish Orphan Biovitrum | |
Postoperative Bleeding Prevention in Massive Bone Tumour Resection | NCT02153593 | Blood Loss Bone Tumour | Tranexamic Acid Fibrin glue Electrocauteriz... | 18 Years - | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | |
Calcitriol in Advanced Intrahepatic Cholangiocarcinoma | NCT01039181 | Advanced Intrah... | Calcitriol | 30 Years - 65 Years | National Science and Technology Development Agency, Thailand | |
Prospective Comparisons of Clinical Trial and Real-world Outcomes in Nasopharyngeal Carcinoma | NCT04108338 | Nasopharyngeal ... | Trial setting | 8 Years - 79 Years | Sun Yat-sen University | |
Evaluation of the Effect of an Specific Oral Nutritional Supplement on the Nutritional Status in Cancer and Malnutrition | NCT04184713 | Malnutrition Cancer Nutrition Relat... | Experimental Gr... Control Group | 28 Years - | Instituto de Investigación Hospital Universitario La Paz | |
Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma | NCT02729506 | Hepatocellular ... | Transarterial R... Transarterial C... | 18 Years - 80 Years | King Faisal Specialist Hospital & Research Center | |
Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors | NCT02283489 | Head and Neck N... | recombinant hum... Cisplatin injec... Paclitaxel inje... | 18 Years - 70 Years | Chengdu Shi Endor Biological Engineering Technology Co., Ltd | |
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer | NCT00131638 | Head and Neck C... | Placebo Palifermin | 18 Years - | Amgen | |
A Study of AMG 820 in Subjects With Advanced Solid Tumors | NCT01444404 | Advanced Malign... Advanced Solid ... Cancer Oncology Oncology Patien... Tumors | AMG 820 | 18 Years - | AmMax Bio, Inc. | |
A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy | NCT00119600 | Anemia Cancer | AMG 114 | 18 Years - | Amgen | |
A Study of AMG 820 in Subjects With Advanced Solid Tumors | NCT01444404 | Advanced Malign... Advanced Solid ... Cancer Oncology Oncology Patien... Tumors | AMG 820 | 18 Years - | AmMax Bio, Inc. | |
A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM) | NCT04573140 | Adult Glioblast... | Autologous tota... | 21 Years - | University of Florida | |
A Study of ZSTK474 in Japanese Patients With Advanced Solid Malignancies | NCT01682473 | Neoplasms | ZSTK474 | 20 Years - | Zenyaku Kogyo Co., Ltd. | |
Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib | NCT01524848 | Gastrointestina... | Pazopanib | 18 Years - | Scandinavian Sarcoma Group | |
Phase II Trial of Allovectin-7® for Head and Neck Cancer | NCT00050388 | Head and Neck C... Squamous Cell C... Head and Neck N... Carcinoma of th... | Allovectin-7® | 18 Years - | Vical | |
Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced Disease | NCT04630743 | Dyspnea Respiratory Ins... Neoplasms Pulmonary Disea... Lung Diseases Heart Failure Lung Diseases, ... Palliative Care Palliative Medi... Breathlessness | Cognitive and B... | 18 Years - | University of Cologne | |
Standardization of Multi-modal Tumor Ablation Therapy System | NCT03223142 | Liver Neoplasms Ablation Techni... Cryoablation Safety Treatment Outco... Neoplasm Metast... Clinical Trial | Multi-modal Pre... | 18 Years - 70 Years | Shanghai Zhongshan Hospital | |
Yiqi Wenjing Prescriptions Preventive Efficacy of Oxaliplatin-induced Peripheral Neuropathy Clinical Trial | NCT04690283 | Chemotherapy-in... Colorectal Canc... | Mimetic granule... Huangqi-Guizhi-... Danggui-Sini gr... | 18 Years - | Nanjing NingQi Medicine Science and Technology Co., Ltd. |